Back to Search
Start Over
Perhexiline maleate in the treatment of angina pectoris. Five years of personal clinical experience.
- Source :
-
The Medical journal of Australia [Med J Aust] 1978 Nov 04; Vol. 2 (10), pp. 466, 493-5. - Publication Year :
- 1978
-
Abstract
- A five-year personal experience of the use of perhexiline maleate (Pexid) in the treatment of severe angina pectoris is presented. Ninety-four patients, all severely incapacitated by cardiac pain, received perhexiline maleate for an average period of 12.2 months. Perhexiline maleate was used either alone or, more commonly, in conjuction with other antianginal therapy, such as beta-adrenergic receptor blocking agents. The results demonstrate that perhexiline maleate is a very effective agent which appears to be safe for long-term usage. Side effects have been frequent, and occasionally bothersome, but all have been transient and dose-dependent. The possibility that the regimens of treatment may materially improve long-term prognosis is raised.
- Subjects :
- Adrenergic beta-Antagonists therapeutic use
Adult
Aged
Angina Pectoris mortality
Angina Pectoris surgery
Australia
Drug Therapy, Combination
Female
Humans
Male
Middle Aged
Myocardial Infarction etiology
Perhexiline adverse effects
Prognosis
Angina Pectoris drug therapy
Perhexiline therapeutic use
Piperidines therapeutic use
Subjects
Details
- Language :
- English
- ISSN :
- 0025-729X
- Volume :
- 2
- Issue :
- 10
- Database :
- MEDLINE
- Journal :
- The Medical journal of Australia
- Publication Type :
- Academic Journal
- Accession number :
- 33322